GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Shuangcheng Pharmaceuticals Co Ltd (SZSE:002693) » Definitions » Research & Development

Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Research & Development : ¥8.4 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Hainan Shuangcheng Pharmaceuticals Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Hainan Shuangcheng Pharmaceuticals Co's Research & Development for the three months ended in Mar. 2024 was ¥3.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥8.4 Mil.


Hainan Shuangcheng Pharmaceuticals Co Research & Development Historical Data

The historical data trend for Hainan Shuangcheng Pharmaceuticals Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Shuangcheng Pharmaceuticals Co Research & Development Chart

Hainan Shuangcheng Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.14 12.18 10.62 14.59 7.96

Hainan Shuangcheng Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.59 1.87 1.51 1.99 3.04

Hainan Shuangcheng Pharmaceuticals Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥8.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hainan Shuangcheng Pharmaceuticals Co  (SZSE:002693) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Hainan Shuangcheng Pharmaceuticals Co Research & Development Related Terms

Thank you for viewing the detailed overview of Hainan Shuangcheng Pharmaceuticals Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Business Description

Traded in Other Exchanges
N/A
Address
16 Xingguo Road, Xiuying District, Haikou, CHN, 570311
Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.
Executives
Yuan Jian Lin Executives
Zhang Wei Executives
Yu Xiao Feng Directors, executives
Wang Xu Guang Executives
Directors, executives
Wang Cheng Dong Directors, executives
Executives
Hu Yi Securities Affairs Representative

Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Headlines

No Headlines